Question 1

Does Linden Advisors own BRIDGEBIO PHARMA stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Linden Advisors holds 239,677,000 shares of BRIDGEBIO PHARMA, worth $266.3M.

Question 2

How many shares of BRIDGEBIO PHARMA does Linden Advisors own?

Accepted Answer

As of its Q2 2026 13F, Linden Advisors holds 239,677,000 shares of BRIDGEBIO PHARMA.

Question 3

What is Linden Advisors' BRIDGEBIO PHARMA position worth?

Accepted Answer

As of its Q2 2026 13F, Linden Advisors' BRIDGEBIO PHARMA position is worth $266.3M.

Question 4

Is Linden Advisors buying or selling BRIDGEBIO PHARMA?

Accepted Answer

In Q2 2026, Linden Advisors increased its BRIDGEBIO PHARMA position by 629,000 shares (+0.3%).

Question 5

When did Linden Advisors first buy BRIDGEBIO PHARMA?

Accepted Answer

Linden Advisors first reported BRIDGEBIO PHARMA in its Q3 2023 13F and has listed it in 12 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	239.7M	+0.3%	$266.3M	1.4%	—	48
2026-Q1	Increased	239M	+11.7%	$268.5M	1.5%	—	54
2025-Q4	Increased	214M	+22.3%	$241M	1.5%	—	58
2025-Q3	Increased	175M	+18.2%	$173.1M	1.2%	—	56
2025-Q2	Increased	148M	+8.2%	$138.6M	0.9%	—	46
2025-Q1	Increased	136.8M	+33.8%	$123.2M	0.8%	—	55
2024-Q4	Increased	102.2M	+15.9%	$87.5M	0.7%	—	48
2024-Q3	Increased	88.2M	+7.3%	$73.8M	0.6%	—	45

BRBRIDGEBIO PHARMA INC